Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Diagnosis and treatment of diabetic foot infections.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS; Infectious Diseases Society of America.

Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S.

PMID:
16799390
2.

Diagnosis and treatment of diabetic foot infections.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS; Infectious Diseases Society of America.

Clin Infect Dis. 2004 Oct 1;39(7):885-910. Epub 2004 Sep 10. No abstract available.

PMID:
15472838
3.

Bone and soft-tissue infections of the lower extremity in diabetics.

LeFrock JL, Joseph WS.

Clin Podiatr Med Surg. 1995 Jan;12(1):87-103. Review.

PMID:
7720035
4.

Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.

LeFrock JL, Ristuccia AM, Ristuccia PA, Quenzer RW, Haggerty PG, Allen JE, Lettau LA, Schwartz R, Appleby D.

Eur J Surg Suppl. 1992;(567):9-13.

PMID:
1381644
5.

Use of ciprofloxacin in podiatric medicine.

LeFrock JL.

J Am Podiatr Med Assoc. 1989 Oct;79(10):497-9.

PMID:
2585281
6.

A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.

Geckler RW, Eng RH, Fabian TC, Echols RM, Jemsek JG, LeFrock JL, Mogabgab WC, Wilson SE.

Am J Surg. 1988 May 31;155(5A):91-5.

PMID:
3287976
7.

Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections.

Poindexter AN, Ritter M, Faro S, Castellano MA, Gentry LO, Ismail M, Knuppel RA, Kreutner AK, Lamb EJ, LeFrock JL, et al.

Am J Obstet Gynecol. 1988 Mar;158(3 Pt 2):717-21. Erratum in: Am J Obstet Gynecol 1989 Apr;160(4):1025.

PMID:
3162652
8.

Vancomycin update.

Smith BR, LeFrock JL.

Am Fam Physician. 1987 May;35(5):223-5. No abstract available.

PMID:
3577993
9.

Drugs for protozoan infections.

Lefrock JL, Smith BR.

Am Fam Physician. 1987 Mar;35(3):247-51. No abstract available.

PMID:
3030085
10.

Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.

LeFrock JL, Smith BR, Chandrasekar P, Rolston KV, Molavi A, Kannangara W.

Arch Intern Med. 1987 Feb;147(2):325-8.

PMID:
3813751
11.

A team approach to infections of the lower extremity in the diabetic patient.

LeFrock JL, Joseph WS.

J Foot Surg. 1987 Jan-Feb;26(1 Suppl):S1-2. No abstract available.

PMID:
3559049
12.

The pathogenesis of diabetic foot infections--immunopathy, angiopathy, and neuropathy.

Joseph WS, LeFrock JL.

J Foot Surg. 1987 Jan-Feb;26(1 Suppl):S7-11. Review. No abstract available.

PMID:
3549853
13.

Cephalosporin, thienamycin, and monobactam antibiotics: a review of antimicrobial activity, pharmacology, and safety.

Smith BR, LeFrock JL.

J Foot Surg. 1987 Jan-Feb;26(1 Suppl):S42-50. Review. No abstract available.

PMID:
3549852
14.

Infections complicating puncture wounds of the foot.

Joseph WS, LeFrock JL.

J Foot Surg. 1987 Jan-Feb;26(1 Suppl):S30-3.

PMID:
2881957
15.

Non-group A beta-hemolytic streptococcal cellulitis.

Rolston KV, LeFrock JL.

Am J Med. 1986 May;80(5):A61. No abstract available.

PMID:
3706358
16.

Cefotetan pharmacokinetics in volunteers with various degrees of renal function.

Smith BR, LeFrock JL, Thyrum PT, Doret BA, Yeh C, Onesti G, Schwartz A, Zimmerman JJ.

Antimicrob Agents Chemother. 1986 May;29(5):887-93.

17.

In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.

Smith BR, LeFrock JL, Donato JB, Joseph WS, Weber SJ.

Antimicrob Agents Chemother. 1986 Feb;29(2):355-8.

18.

Drugs of choice for bacterial meningitis.

LeFrock JL.

Am Fam Physician. 1986 Feb;33(2):285-91. No abstract available.

PMID:
3484890
19.

Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.

Smith BR, LeFrock JL, McCloskey RV, Donato JB, Weber SJ, Joseph WS.

Antimicrob Agents Chemother. 1986 Feb;29(2):346-9.

20.

Health advice for the international traveler.

Weber SJ, Lefrock JL.

Am Fam Physician. 1985 Dec;32(6):165-9. No abstract available.

PMID:
4072869
21.

Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections.

LeFrock JL, Johnson ES, Smith LG, Rosenberg E.

Am J Med. 1985 Nov 29;79(5B):122-5. No abstract available.

PMID:
3907339
22.
23.

Clinical features and antimicrobial therapy of infections caused by group G streptococci.

Rolston KV, Chandrasekar PH, LeFrock JL.

Infection. 1985 Sep-Oct;13(5):203-6.

PMID:
4066043
24.

Treatment of helminthic diseases.

Lefrock JL, Smith BR.

Am Fam Physician. 1985 Sep;32(3):182-8. No abstract available.

PMID:
4036773
25.

Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporin.

LeFrock JL, Smith BR, Bihl J.

Antimicrob Agents Chemother. 1985 Jul;28(1):133-7.

26.

Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.

Smith BR, LeFrock JL.

Drug Intell Clin Pharm. 1985 Jun;19(6):415-20. Review.

PMID:
3891282
27.

Antibiotic therapy for anaerobic infections.

Weber SJ, Lefrock JL.

Am Fam Physician. 1985 Apr;31(4):212-6. No abstract available.

PMID:
3984824
28.

A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections.

LeFrock JL, Carr BB, Blias F, Schell RF, Dematteo C, Tillotson JR.

Drug Intell Clin Pharm. 1985 Apr;19(4):309-15.

PMID:
3891278
29.

Tuberculous meningitis.

Molavi A, LeFrock JL.

Med Clin North Am. 1985 Mar;69(2):315-31.

PMID:
3990437
30.

Gram-negative bacillary meningitis.

LeFrock JL, Smith BR, Molavi A.

Med Clin North Am. 1985 Mar;69(2):243-56.

PMID:
3872980
31.

Drug therapy for sexually transmitted diseases.

Rosenberg M, Lefrock JL.

Am Fam Physician. 1985 Feb;31(2):256-60. Review. No abstract available.

PMID:
3919545
32.

Treatment of anaerobic infections of the central nervous system.

Chandrasekar PH, Lefrock JL.

Indian J Pathol Microbiol. 1985 Jan;28(1):7-16. Review. No abstract available.

PMID:
3914459
33.
34.

Cefmenoxime therapy in bacterial osteomyelitis.

Sheftel TG, Cierny G 3rd, Lefrock JL, Mader JT.

Am J Med. 1984 Dec 21;77(6A):17-20.

PMID:
6097118
35.

Effective systemic antifungal agents.

Lefrock JL, Smith BR.

Am Fam Physician. 1984 Dec;30(6):162-7. No abstract available.

PMID:
6095631
36.

Inhibition of macrophage C3b-mediated ingestion by syphilitic hamster T cell-enriched fractions.

Tabor DR, Azadegan AA, Schell RF, Lefrock JL.

J Immunol. 1984 Nov;133(5):2698-705.

PMID:
6237153
37.

Effectiveness of cefotaxime in gram-negative meningitis.

LeFrock JL, Molavi A, Smith B, Black P, Rosenberg M, Rolston K, Brodner R, Chandrasekar P, Henao L, Kannangara DW.

Neurosurgery. 1984 Nov;15(5):679-82.

PMID:
6095133
38.

Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins.

Khan NJ, Bihl JA, Schell RF, LeFrock JL, Weber SJ.

Antimicrob Agents Chemother. 1984 Oct;26(4):585-90.

39.

Hot tub-associated dermatitis due to Pseudomonas aeruginosa. Case report and review of the literature.

Chandrasekar PH, Rolston KV, Kannangara DW, LeFrock JL, Binnick SA.

Arch Dermatol. 1984 Oct;120(10):1337-40.

PMID:
6435541
40.

Diffusion of ceftriaxone into the cerebrospinal fluid of adults.

Chandrasekar PH, Rolston KV, Smith BR, LeFrock JL.

J Antimicrob Chemother. 1984 Oct;14(4):427-30.

PMID:
6094424
41.

Treatment of infectious arthritis.

LeFrock JL, Kannangara DW.

Am Fam Physician. 1984 Sep;30(3):252-7. No abstract available.

PMID:
6475706
42.

Enterococcal superinfection and colonization with aztreonam therapy.

Chandrasekar PH, Smith BR, LeFrock JL, Carr B.

Antimicrob Agents Chemother. 1984 Aug;26(2):280-2.

43.

In vitro susceptibility of group G streptococci with regard to tolerance.

Rolston KV, LeFrock JL.

Am J Med. 1984 Jul;77(1):A72, A77. No abstract available.

PMID:
6741969
44.

Drug therapy for bacterial osteomyelitis.

Lefrock JL, Smith BR, Molavi A.

Am Fam Physician. 1984 Jul;30(1):213-6. No abstract available.

PMID:
6464951
45.

Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.

LeFrock JL, Molavi A, McCloskey RV, Rolston K, Chandrasekar P, Henao L, Smith BR, Kannangara W, Schell RF, Carr BB.

Am J Med. 1984 Jul;77(1):72-8.

PMID:
6331163
46.

Cobra venom factor abrogates passive humoral resistance to syphilitic infection in hamsters.

Azadegan AA, Tabor DR, Schell RF, LeFrock JL.

Infect Immun. 1984 Jun;44(3):740-2.

47.

Amikacin levels in the human biliary tract.

LeFrock JL, Schell RF, Siskind S, Carr BB.

J Clin Pharmacol. 1984 May-Jun;24(5-6):247-54.

PMID:
6747021
48.

Management of osteomyelitis and soft-tissue infections.

LeFrock JL, Rolston KV, Molavi A.

Del Med J. 1984 May;56(5):289-96. Review. No abstract available.

PMID:
6376178
49.

The nonprophylactic role of cephalosporins in obstetrics and gynecology.

LeFrock JL, Smith BR, Molavi A.

Bull N Y Acad Med. 1984 May;60(4):416-25. Review. No abstract available.

50.

The nonprophylactic role of cephalosporins in surgery.

LeFrock JL, Molavi A, Smith BR.

Bull N Y Acad Med. 1984 May;60(4):394-402. Review. No abstract available.

Supplemental Content

Loading ...
Support Center